Forte Biosciences, Inc.
FBRXDelisted Aug 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Forte Biosciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q3 2024
- Shares held
- 4.28M
- +3.54M (+480.5%) vs. Q3 2024
- Total value
- $97.1M
- +$93.0M (+2,256.8%) vs. Q3 2024
- New holders
- 9
- 6 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $432.7M |
| Q1 2026 | 68 | $350.2M |
| Q4 2025 | 59 | $314.5M |
| Q3 2025 | 42 | $155.1M |
| Q2 2025 | 34 | $130.4M |
| Q1 2025 | 30 | $40.4M |
| Q4 2024 | 26 | $97.1M |
| Q3 2024 | 24 | $4.12M |
| Q2 2024 | 34 | $10.2M |
| Q1 2024 | 33 | $13.3M |
| Q4 2023 | 35 | $15.5M |
| Q3 2023 | 31 | $11.1M |
| Q2 2023 | 31 | $3.60M |
| Q1 2023 | 31 | $3.90M |
| Q4 2022 | 34 | $3.80M |
| Q3 2022 | 33 | $2.85M |
| Q2 2022 | 40 | $3.01M |
| Q1 2022 | 52 | $5.68M |
| Q4 2021 | 52 | $11.5M |
| Q3 2021 | 58 | $12.8M |
| Q2 2021 | 75 | $289.4M |
| Q1 2021 | 62 | $273.1M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| REAP Financial Group, LLC | 3 | $68 | 0.00% | 00.0% | Unchanged |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 7 | $107 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 8 | $182 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 10 | $227 | 0.00% | −13−56.5% | Reduced |
| SBI Securities Co., Ltd. | 12 | $273 | 0.00% | +12 | New |
| Private Trust Co NA | 42 | $954 | 0.00% | +42 | New |
| Comerica Bank | 56 | $1.27K | 0.00% | +56 | New |
| Tower Research Capital LLC (TRC) | 100 | $2.27K | 0.00% | −706−87.6% | Reduced |
| Group One Trading, L.P. | 104 | $2.36K | 0.00% | −455−81.4% | Reduced |
| Morgan Stanley | 151 | $3.43K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,103 | $47.8K | 0.00% | +2,100+70,000.0% | Added |
| Royal Bank of Canada | 3,784 | $86.0K | 0.00% | +3,784 | New |
| BlackRock, Inc. | 6,803 | $154.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 16,877 | $383.4K | 0.00% | +2,607+18.3% | Added |
| Acuta Capital Partners, LLC | 18,139 | $411.9K | 0.41% | +18,139 | New |
| Vanguard Group Inc | 26,394 | $599.4K | 0.00% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 35,000 | $794.9K | 0.00% | −37,413−51.7% | Reduced |
| Boothbay Fund Management, LLC | 89,191 | $2.03M | 0.06% | +89,191 | New |
| Perceptive Advisors LLC | 95,742 | $2.17M | 0.06% | 00.0% | Unchanged |
| Woodline Partners LP | 204,275 | $4.64M | 0.03% | +204,275 | New |
| Cable Car Capital LLC | 219,604 | $4.99M | 0.38% | +138,325+170.2% | Added |
| BVF Inc | 594,282 | $13.5M | 0.46% | +475,000+398.2% | Added |
| OrbiMed Advisors LLC | 600,000 | $13.6M | 0.28% | +600,000 | New |
| Ikarian Capital, LLC | 609,225 | $13.8M | 3.95% | +609,225 | New |
| Tybourne Capital Management (HK) Ltd | 619,981 | $14.1M | 3.53% | +475,000+327.6% | Added |
| Fred Alger Management, LLC | 1,133,944 | $25.8M | 0.12% | +1,051,246+1,271.2% | Added |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −70,468−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,096−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,606−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |